Parallel Advisors, LLC 10x Genomics, Inc. Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 17,223 shares of TXG stock, worth $246,461. This represents 0.01% of its overall portfolio holdings.

Number of Shares
17,223
Previous 16,105 6.94%
Holding current value
$246,461
Previous $313,000 23.96%
% of portfolio
0.01%
Previous 0.01%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$15.71 - $23.49 $17,563 - $26,261
1,118 Added 6.94%
17,223 $388,000
Q2 2024

Aug 08, 2024
SELL
$19.45 - $37.37 $9,511 - $18,273
-489 Reduced 2.95%
16,105 $313,000
Q1 2024

May 06, 2024
SELL
$36.08 - $54.3 $252 - $380
-7 Reduced 0.04%
16,594 $622,000
Q4 2023

Feb 09, 2024
SELL
$34.32 - $57.55 $26,529 - $44,486
-773 Reduced 4.45%
16,601 $928,000
Q3 2023

May 20, 2024
BUY
$40.86 - $62.98 $163 - $251
4 Added 0.02%
17,374 $716,000
Q3 2023

Nov 13, 2023
BUY
$40.86 - $62.98 $163 - $251
4 Added 0.02%
17,374 $716,000
Q2 2023

May 20, 2024
SELL
$50.96 - $58.72 $458 - $528
-9 Reduced 0.05%
17,370 $969,000
Q2 2023

Aug 04, 2023
SELL
$50.96 - $58.72 $458 - $528
-9 Reduced 0.05%
17,370 $969,000
Q1 2023

May 20, 2024
BUY
$35.33 - $55.79 $27,734 - $43,795
785 Added 4.73%
17,379 $969,000
Q1 2023

Apr 25, 2023
SELL
$35.33 - $55.79 $106,343 - $167,927
-3,010 Reduced 14.76%
17,379 $969,000
Q4 2022

Feb 03, 2023
BUY
$24.4 - $41.3 $3,757 - $6,360
154 Added 0.76%
20,389 $742,000
Q3 2022

Nov 10, 2022
BUY
$28.48 - $52.59 $1,965 - $3,628
69 Added 0.34%
20,235 $576,000
Q2 2022

Aug 01, 2022
SELL
$36.95 - $82.41 $2,512 - $5,603
-68 Reduced 0.34%
20,166 $913,000
Q1 2022

Apr 28, 2022
BUY
$55.7 - $145.79 $713,517 - $1.87 Million
12,810 Added 172.55%
20,234 $1.51 Million
Q4 2021

Jan 20, 2022
BUY
$135.05 - $182.59 $1 Million - $1.35 Million
7,414 Added 74140.0%
7,424 $1.11 Million
Q3 2021

Nov 02, 2021
SELL
$145.58 - $192.14 $145 - $192
-1 Reduced 9.09%
10 $1,000
Q2 2021

Aug 06, 2021
SELL
$134.22 - $202.37 $465,609 - $702,021
-3,469 Reduced 99.68%
11 $2,000
Q1 2021

Apr 23, 2021
BUY
$140.25 - $196.86 $485,545 - $681,529
3,462 Added 19233.33%
3,480 $630,000
Q4 2020

Feb 02, 2021
BUY
$126.47 - $163.7 $2,276 - $2,946
18 New
18 $3,000

Others Institutions Holding TXG

# of Institutions
290
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.36B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email